On May 14, 2026, Collegium Pharmaceutical, Inc. held its Annual Meeting where shareholders elected eight directors and approved executive compensation and Deloitte & Touche LLP as the accounting firm for 2026, with 29,210,926 shares represented out of 32,406,969 entitled to vote.